The Finance Shelf

Funder directory / Spain / Venture capital firms

Ysios Capital

Venture capitalBarcelona, Spainysioscapital.comVerified 9 Nov 2026

Ysios Capital is a life sciences venture capital firm that invests globally in biotechnology companies. The firm focuses on funding biotech ventures developing novel therapeutic drugs and technologies from company creation through late preclinical and clinical development stages.

StagesSeed · Series A · Series B+
Invests inEurope · US
Deals recorded34
Fund sizeWe manage over €400M ($500M ) in assets across three glob…quoted from their site

What they invest in

  • We are a leading life sciences investor financing highly innovative companies worldwide. source
  • We provide biotech ventures with the resources to develop novel therapies for indications with high unmet medical needs. source
  • We invest globally in biotech ventures, focusing exclusively on innovative therapeutic drugs. source

Latest investments

All 34 dealsPRO
CompanyRoundAmountDateCo-investorsSource
Vivet Therapeutics––––Portfolio page
VarmX
NL
––––Portfolio page
TiGenix
ES
––––Portfolio page
Tagworks Pharmaceuticals
NL
––––Portfolio page
Synendos
CH
––––Portfolio page

Exits

  • TiGenix Acquired by Takeda Pharmaceuticals2018 · Source
  • AM Pharma Acquired by Ambrose HealthcareSource
  • BioVex Acquired by AmgenSource
  • EndoSense Acquired by St Jude Medical/AbbottSource
  • Fusion Pharmaceuticals Acquired by AstrazenecaSource
  • AELIX Therapeutics Acquired by Gilead SciencesSource
  • Neurona Therapeutics Acquired by UCBSource
  • Sanifit Acquired by Vifor PharmaSource
  • STAT Dx Acquired by QiagenSource
  • Memo Therapeutics Acquired by IPSENSource

Shown only when an exit is documented by a public source.

Similar funders